BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21339534)

  • 41. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
    Martin E; Mukherjee P
    J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards cheminformatics-based estimation of drug therapeutic index: Predicting the protective index of anticonvulsants using a new quantitative structure-index relationship approach.
    Chen S; Zhang P; Liu X; Qin C; Tao L; Zhang C; Yang SY; Chen YZ; Chui WK
    J Mol Graph Model; 2016 Jun; 67():102-10. PubMed ID: 27262528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study of QSAR/QSPR correlations using support vector machines, radial basis function neural networks, and multiple linear regression.
    Yao XJ; Panaye A; Doucet JP; Zhang RS; Chen HF; Liu MC; Hu ZD; Fan BT
    J Chem Inf Comput Sci; 2004; 44(4):1257-66. PubMed ID: 15272833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 4D-fingerprints, universal QSAR and QSPR descriptors.
    Senese CL; Duca J; Pan D; Hopfinger AJ; Tseng YJ
    J Chem Inf Comput Sci; 2004; 44(5):1526-39. PubMed ID: 15446810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development predictive QSAR models for artemisinin analogues by various feature selection methods: a comparative study.
    Abbasitabar F; Zare-Shahabadi V
    SAR QSAR Environ Res; 2012 Jan; 23(1-2):1-15. PubMed ID: 22040327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection.
    Nantasenamat C; Monnor T; Worachartcheewan A; Mandi P; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2014 Apr; 76():352-9. PubMed ID: 24589490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem.
    Wong WW; Burkowski FJ
    J Cheminform; 2009 Apr; 1():4. PubMed ID: 20142987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extension of molecular similarity analysis approach to classification of DNA sequences using DNA descriptors.
    Jayalakshmi R; Natarajan R; Vivekanandan M
    SAR QSAR Environ Res; 2011 Mar; 22(1-2):21-34. PubMed ID: 21391139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of combinatorial clustering methods on pharmacological data sets represented by machine learning-selected real molecular descriptors.
    Rivera-Borroto OM; Marrero-Ponce Y; García-de la Vega JM; Grau-Ábalo Rdel C
    J Chem Inf Model; 2011 Dec; 51(12):3036-49. PubMed ID: 22098113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of support vector machine (SVM) for prediction toxic activity of different data sets.
    Zhao CY; Zhang HX; Zhang XY; Liu MC; Hu ZD; Fan BT
    Toxicology; 2006 Jan; 217(2-3):105-19. PubMed ID: 16213080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of pharmacophore similarity-based quantitative activity hypothesis and its applicability domain: applied on a diverse data-set of HIV-1 integrase inhibitors.
    Kumar SP; Jasrai YT; Mehta VP; Pandya HA
    J Biomol Struct Dyn; 2015; 33(4):706-22. PubMed ID: 24735019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QSAR modeling of datasets with enantioselective compounds using chirality sensitive molecular descriptors.
    Kovatcheva A; Golbraikh A; Oloff S; Feng J; Zheng W; Tropsha A
    SAR QSAR Environ Res; 2005; 16(1-2):93-102. PubMed ID: 15844445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination and mapping of activity-specific descriptor value ranges for the identification of active compounds.
    Eckert H; Bajorath J
    J Med Chem; 2006 Apr; 49(7):2284-93. PubMed ID: 16570925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach.
    Basak SC
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):449-62. PubMed ID: 24138422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TMACC: interpretable correlation descriptors for quantitative structure-activity relationships.
    Melville JL; Hirst JD
    J Chem Inf Model; 2007; 47(2):626-34. PubMed ID: 17381177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of antibacterial compounds by machine learning approaches.
    Yang XG; Chen D; Wang M; Xue Y; Chen YZ
    J Comput Chem; 2009 Jun; 30(8):1202-11. PubMed ID: 18988254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ChemModLab: a web-based cheminformatics modeling laboratory.
    Hughes-Oliver JM; Brooks AD; Welch WJ; Khaledi MG; Hawkins D; Young SS; Patil K; Howell GW; Ng RT; Chu MT
    In Silico Biol; 2011-2012; 11(1-2):61-81. PubMed ID: 22475752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors.
    Basak SC; Mills D; Mumtaz MM
    SAR QSAR Environ Res; 2007; 18(1-2):45-55. PubMed ID: 17365958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adaptive variable-weighted support vector machine as optimized by particle swarm optimization algorithm with application of QSAR studies.
    Wen JH; Zhong KJ; Tang LJ; Jiang JH; Wu HL; Shen GL; Yu RQ
    Talanta; 2011 Mar; 84(1):13-8. PubMed ID: 21315891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural similarity and descriptor spaces for clustering and development of QSAR models.
    Ruiz IL; García GC; Gómez-Nieto MA
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):254-71. PubMed ID: 23700995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.